Link to INSAR website for more information

Translation in Fast Forward: Cross Species Research on Deletions and Duplications of Chromosome 15q11.2-q13

Panel Presentation

Friday, May 3, 2019: 3:55 PM

Room: 517C (Palais des congres de Montreal)

J. L. Silverman, MIND Institute and Department of Psychiatry and Behavioral Sciences, University of California Davis School of Medicine, Sacramento, CA

Background:

Mutations in chromosomal region 15q11.2-q13 result in at least three neurodevelopmental disorders including Angelman, Prader-Willi and Dup15q Syndromes, all associated with autism spectrum disorders (ASD). Angelman Syndrome (AS) is a rare neurodevelopmental disorder characterized by developmental delay, impaired receptive and expressive communication skills, ataxia, motor and balance deficits, poor attention, intellectual disabilities, microcephaly, and seizures. The genetic cause of AS is loss of expression of UBE3A (ubiquitin-protein ligase E6-AP) in the brain, typically due to a deletion of the maternal 15q11-q13 region. Duplications or triplications of chromosome 15q11.2-q13 (Dup15q) are one of the most common and penetrant genomic rearrangements observed in ASD, accounting for up to ~3% of cases. New advances in mouse and rat models have allowed for the development and utilization of clinically-relevant behavioral assays to measure sophisticated outcomes of social communication, fine grained motor skills, and learning and memory with neurophysiological outcomes such as spiking events, spectral power and sleep.

Objectives:

To examine clinically-relevant behavior, neuroanatomy by MRI, and neurophysiology by electroencephalographic (EEG) in our Ube3a deletion rats and an Ube3a overexpression mouse model system.